EUROPE SMART INHALERS MARKET FORECAST 2019-2028

EUROPE SMART INHALERS MARKET FORECAST 2019-2028

  • July 2020 •
  • Report ID: 5917873 •
  • Format: PDF
KEY FINDINGS
The Europe smart inhalers market is predicted to register a CAGR of 32.11% over the estimated period, 2019-2028. An increase in the incidence of COPD and asthma, a rise in awareness about these diseases, an increase in the geriatric population, and an upsurge in demand for new emerging technologies boost the market growth in the region.

MARKET INSIGHTS
The study of the Europe smart inhalers market growth is based on the market performance of Belgium, Russia, Germany, Italy, the UK, Poland, France, and the rest of Europe Denmark, Norway, Austria, Swede, Netherlands, and Spain.Italy spends about 9% of the GDP each year on healthcare as per OECD.

The prevalence of respiratory diseases, with consistent healthcare expenditure on research activities, as well as contributions by societies to raise awareness, are expected to help in the steady growth of the market.In countries like Belgium, lifestyle disorders, such as smoking and alcohol consumption, are some of the crucial contributors to respiratory disorders, which require home healthcare services.

There are growing initiatives to increase telereporting and teleconsultations, which propel the demand for inhalers and nebulizers in-home healthcare settings.
In Poland, the growing prevalence of cystic fibrosis, as well as rising COPD disease, is expected to augment the market growth.COPD is a major social burden, as 20 thousand disability pensions are granted every year, due to this disease.

The rest of Europe also spend majorly on healthcare as per GDP about the median of OECD, which makes this region lucrative for market growth.

COMPETITIVE INSIGHTS
Some of the prominent companies operating in the market are GlaxoSmithKline Plc, Agilent Technologies Inc, 3M Company, Boehringer Ingelheim International GmbH, Koninklijke Philips N.V., etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. 3M COMPANY
2. ADHERIUM LIMITED
3. AGILENT TECHNOLOGIES INC
4. ASTRAZENECA PLC
5. BOEHRINGER INGELHEIM GMBH
6. COHERO HEALTH INC
7. GLAXOSMITHKLINE PLC
8. KONINKLIJKE PHILIPS NV
9. NOVARTIS AG
10. OPKO HEALTH INC
11. RESMED INC (PROPELLER HEALTH)
12. TEVA PHARMACEUTICAL INDUSTRIES LIMITED
13. VECTURA GROUP PLC